This article refers to:
Article title: The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States Authors: Michele A. Kohli, Michael Maschio, Keya Joshi, Amy Lee, Kelly Fust, Ekkehard Beck, Nicolas Van de Velde and Milton C. Weinstein Journal: Journal of Medical Economics Bibliometrics: Volume 26, Number 1, pages 1532–1545 DOI: https://doi.org/10.1080/13696998.2023.2281083 The authors have chosen to include a Graphical Abstract in this article following publication. This is intended to highlight the content of the article.